NCT02474901View on ClinicalTrials.gov

Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

December 31, 2016

Conditions
Human Immunodeficiency Virus (HIV)
Interventions
BIOLOGICAL

Quadrivalent Live Attenuated Influenza Vaccine

Trial Locations (1)

80045

University of Colorado Denver, Denver

Sponsors

Collaborators (1)

MedImmune LLC
All Listed Sponsors
collaborator

MedImmune LLC

INDUSTRY

lead

University of Colorado, Denver

OTHER